BUZZ-Shire: shares do U-turn after misses Q2 forecast
** Shire (Xetra: S7E.DE - news) , which spent the morning among the FTSE 100's top risers, left nursing 2.3% drop which puts it near bottom of index as misses market expectations for Q2 earnings
** Blames lower sales of its ADHD drug Intuniv following the introduction of generic competition
** Non-GAAP EPS of $2.63 vs $2.80 forecast by analysts
** One of most actively traded UK blue-chip stocks, with nearly all of its 90-day daily avg volume having gone through (RM (LSE: RM.L - news) : tricia.wright1.thomsonreuters.com@reuters.net)